Cue Biopharma Inc (CUE)
1.07
+0.04
(+3.88%)
USD |
NASDAQ |
Nov 22, 11:37
Cue Biopharma Market Cap: 67.78M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 65.25M |
| November 20, 2024 | 69.05M |
| November 19, 2024 | 68.42M |
| November 18, 2024 | 69.69M |
| November 15, 2024 | 78.87M |
| November 14, 2024 | 95.03M |
| November 13, 2024 | 95.03M |
| November 12, 2024 | 107.70M |
| November 11, 2024 | 112.59M |
| November 08, 2024 | 103.56M |
| November 07, 2024 | 107.17M |
| November 06, 2024 | 99.34M |
| November 05, 2024 | 102.96M |
| November 04, 2024 | 89.71M |
| November 01, 2024 | 91.52M |
| October 31, 2024 | 96.93M |
| October 30, 2024 | 105.36M |
| October 29, 2024 | 101.75M |
| October 28, 2024 | 107.17M |
| October 25, 2024 | 89.11M |
| October 24, 2024 | 93.92M |
| October 23, 2024 | 94.53M |
| October 22, 2024 | 96.33M |
| October 21, 2024 | 101.15M |
| October 18, 2024 | 72.85M |
| Date | Value |
|---|---|
| October 17, 2024 | 66.83M |
| October 16, 2024 | 64.42M |
| October 15, 2024 | 67.43M |
| October 14, 2024 | 72.85M |
| October 11, 2024 | 74.06M |
| October 10, 2024 | 80.08M |
| October 09, 2024 | 72.55M |
| October 08, 2024 | 74.06M |
| October 07, 2024 | 83.39M |
| October 04, 2024 | 69.84M |
| October 03, 2024 | 49.32M |
| October 02, 2024 | 44.16M |
| October 01, 2024 | 43.33M |
| September 30, 2024 | 45.59M |
| September 27, 2024 | 33.05M |
| September 26, 2024 | 22.09M |
| September 25, 2024 | 23.11M |
| September 24, 2024 | 23.58M |
| September 23, 2024 | 23.31M |
| September 20, 2024 | 25.49M |
| September 19, 2024 | 27.48M |
| September 18, 2024 | 26.93M |
| September 17, 2024 | 27.73M |
| September 16, 2024 | 27.41M |
| September 13, 2024 | 28.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
22.09M
Minimum
Sep 26 2024
874.26M
Maximum
Jun 02 2020
261.27M
Average
168.83M
Median
May 26 2023
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.22B |
| Arbutus Biopharma Corp | 659.43M |
| GlycoMimetics Inc | 20.31M |
| FibroGen Inc | 39.30M |
| Cidara Therapeutics Inc | 134.94M |
Market Cap Related Metrics
| PS Ratio | 5.558 |
| Price to Book Value | 2.672 |
| Price | 1.07 |
| Earnings Yield | -85.05% |